The Middle East and Africa Interventional Neurology Market size was worth USD 168.81 million in 2022 and estimated to reach USD 254.54 million by the end of 2027, with a growing potential of 8.56%.
The occurrence rate of stroke has been estimated to be 316 per 100,000 every year in Africa. In turn, it will lead to growing occurrences of neurological disorders, which are set to bolster the market demand. The existence of a vast patient population and rising senior population are leveraging the market growth. The growing number of healthcare problems and increasing huge cases pertaining to diseases are likely to increase the demand for interventional neurology. Adoption of unhealthy dietary habits and lifestyle changes are surging the market growth. The high, increasing occurrence of brain stroke and aneurysm are majorly responsible for the growing demand for the neurology devices market. With rising cases of obesity in people, expansion in per capita income is mounting the market growth.
However, strict administrative policies by the U.S FDA for approving the neurology devices are likely to restrain the market growth. The scarcity of experienced professionals in neurology is curbing the growing demand for the interventional neurology market.
This market research report on the Middle East and Africa Neurovascular Devices/Interventional Neurology Market has been segmented and sub-segmented into the following categories.
By Technology:
By Product:
By End User:
By Country:
Regional Analysis:
Geographically, South Africa is leading the market with the majority of the share. Intensifying difficulties in treating patients suffering from stroke are leveraging the growth of the market. Accessibility of favorable reimbursement policies in the healthcare sector and identifying the advantages of the interventional neurology market intensifies the growth. The introduction of new technology advancements, a huge patient population, and an increase in efficient neurovascular are escalating the market demand. UAE is next to South Africa is leading the market. The aging population in UAE, aged 65years and above, was 1,13,000, and the count is predicted to reach 5,48,000 by the end of 2030. UAE is having a vast older population leading to a growing requirement for neurological diseases associated treatment impelling the market. The rest of the MEA is expected to have notable growth in the market.
Key players in the Middle East and Africa Interventional Neurology Market are Stryker Corporation, Merit Medical Systems Inc., Medtronic plc, Terumo Corporation, Johnson & Johnson, Microport Scientific Corporation, Penumbra Inc., Abbott Laboratories, W. L. Gore & Associates Inc., and Medikit Co., Ltd.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Introduction
5.1.2 Embolization and Coiling
5.1.3 Angioplasty
5.1.4 Carotid Stenting
5.1.5 Neurothrombectomy
5.1.6 Micro support devices
5.1.7 Others
5.1.8 Y-o-Y Growth Analysis, By Technology
5.1.9 Market Attractiveness Analysis, By Technology
5.1.10 Market Share Analysis, By Technology
5.2 Product
5.2.1 Introduction
5.2.2 Carotid Stent
5.2.3 Microcatheter
5.2.4 Flow Diversion
5.2.5 Microguidewires
5.2.6 Suction Device
5.2.7 stenting systems
5.2.8 Clot Retrieval
5.2.9 Others
5.2.10 Y-o-Y Growth Analysis, By Product
5.2.11 Market Attractiveness Analysis, By Product
5.2.12 Market Share Analysis, By Product
5.3 End-users
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Ambulatory centers
5.3.4 Neurology clinics
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By End-users
5.3.7 Market Attractiveness Analysis, By End-users
5.3.8 Market Share Analysis, By End-users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Product
6.1.3.4 By End-users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Product
6.1.4.4 By End-users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Product
6.1.5.4 By End-users
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Stryker Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic plc
8.3 Johnson & Johnson
8.4 Terumo Corporation
8.5 Penumbra Inc.
8.6 Abbott Laboratories
8.7 Merit Medical Systems Inc.
8.8 W. L. Gore & Associates Inc.
8.9 Microport Scientific Corporation
8.10 Medikit Co., Ltd
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
